HOME › DRUGS › RISANKIZUMAB
ACTIVE SUBSTANCE / INN

RISANKIZUMAB

Brand name(s): Skyrizi
EMA LISTED
AUTHORISED
Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative;Crohn Dis…
ACTIVE SUBSTANCE
Risankizumab
REGULATORS
EMA
SPONSORS / MAH
AbbVie Deutschland GmbH & Co. KG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SkyriziAbbVie Deutschland GmbH & Co. KGAuthorised26/04/2019Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative;Crohn Disease

FULL INTELLIGENCE ON RISANKIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →